KCNK18 and migraine disorder: A more recent study using the genome editing technique CRISPR-Cas9 was adopted to correct the F139WfsX24 mutation and display a reversal of the neuronal hyperexcitability, which linked the clinical phenotype to the mutation and further strengthened the concept that TRESK plays a role in migraine and aura mechanisms [134].